RU98118763A -
METHOD FOR TREATING PRIMARY ARTERIAL HYPERTENSION
- Google Patents
METHOD FOR TREATING PRIMARY ARTERIAL HYPERTENSION
Info
Publication number
RU98118763A
RU98118763ARU98118763/14ARU98118763ARU98118763ARU 98118763 ARU98118763 ARU 98118763ARU 98118763/14 ARU98118763/14 ARU 98118763/14ARU 98118763 ARU98118763 ARU 98118763ARU 98118763 ARU98118763 ARU 98118763A
1. Способ лечения первичной артериальной гипертензии, включающий применение ингибитора ангиотензинпревращающего фермента, отличающийся тем, что дополнительно применяют антиоксидант, при этом прием антиоксиданта производят на фоне постоянного приема ингибитора ангиотензинпревращающего фермента в три курса продолжительностью по месяцу и с промежутком между курсами в 4-5 месяцев.1. A method of treating primary arterial hypertension, including the use of an angiotensin converting enzyme inhibitor, characterized in that the antioxidant is additionally used, while the antioxidant is taken against a background of continuous administration of an angiotensin converting enzyme inhibitor in three courses lasting a month and with an interval between courses of 4-5 months . 2. Способ по п.1, отличающийся тем, что в качестве антиоксиданта применяют α-токоферола ацетат. 2. The method according to claim 1, characterized in that α-tocopherol acetate is used as an antioxidant.
RU98118763A1998-10-081998-10-08Method of treatment of patients with essential hypertension
RU2164410C2
(en)
A retro-inverso analogue of the (5-14) decapeptide of equine angiotensinogen, as a specific renin inhibitor with high resistance to enzymatic hydrolysis
Fixed-dose composition of an angiotensin-converting enzyme inhibitor and a calcium channel antagonist, method for its preparation and its use in the treatment of cardiovascular diseases
COMPOSITION CONTAINING AN INHIBITOR OF SIGNAL TRANSDUCTION OF HETEROMETRIC G PROTEINS IN COMBINATION WITH AN ANTIHYPERTENSIVE AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF ARTERIAL HYPERTENSION
USE OF 2-METHOXYPHENYL-1-METHYL-5P-METHYL-BENZOYLPYRROL-2-ACETAMIDO ACETATE FOR THE PRODUCTION OF AN ANTI-IGNITANT WITH PREVENTING STOMACH HYPERSECRETION AND KIDNEY Dysfunction